NL7714054A - Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking. - Google Patents

Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking.

Info

Publication number
NL7714054A
NL7714054A NL7714054A NL7714054A NL7714054A NL 7714054 A NL7714054 A NL 7714054A NL 7714054 A NL7714054 A NL 7714054A NL 7714054 A NL7714054 A NL 7714054A NL 7714054 A NL7714054 A NL 7714054A
Authority
NL
Netherlands
Prior art keywords
propyloximes
medicine
preparing
preparation
blood pressure
Prior art date
Application number
NL7714054A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NL7714054A publication Critical patent/NL7714054A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NL7714054A 1976-12-24 1977-12-19 Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking. NL7714054A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762658938 DE2658938A1 (de) 1976-12-24 1976-12-24 Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NL7714054A true NL7714054A (nl) 1978-06-27

Family

ID=5996701

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7714054A NL7714054A (nl) 1976-12-24 1977-12-19 Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking.

Country Status (24)

Country Link
US (1) US4328227A (OSRAM)
JP (4) JPS5379875A (OSRAM)
AT (1) AT360544B (OSRAM)
AU (1) AU512353B2 (OSRAM)
BE (1) BE862303A (OSRAM)
CA (1) CA1105933A (OSRAM)
DE (1) DE2658938A1 (OSRAM)
DK (1) DK575277A (OSRAM)
ES (3) ES465204A1 (OSRAM)
FI (1) FI773903A7 (OSRAM)
FR (1) FR2375225A1 (OSRAM)
GB (1) GB1543517A (OSRAM)
GR (1) GR70042B (OSRAM)
HU (1) HU177453B (OSRAM)
IE (1) IE46226B1 (OSRAM)
IL (1) IL53674A (OSRAM)
IT (1) IT1089233B (OSRAM)
LU (1) LU78770A1 (OSRAM)
NL (1) NL7714054A (OSRAM)
NO (1) NO774456L (OSRAM)
PL (3) PL110753B1 (OSRAM)
PT (1) PT67444B (OSRAM)
SE (1) SE7714685L (OSRAM)
ZA (1) ZA777586B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704604A1 (de) * 1987-02-13 1988-08-25 Mack Chem Pharm Oximether von 2,6-dioxabicyclo(3.3.0)octanonen, herstellungsverfahren und anwendung als arzneimittel
HU212415B (en) * 1989-08-25 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components
DE4306392A1 (de) * 1993-03-02 1994-09-08 Basf Ag ß-Hydroxyoximether und bei Raumtemperatur mit ß-Hydroxyoximethern vernetzbare Dispersionen oder Lösungen
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6048876A (en) * 1995-01-23 2000-04-11 Suntory Limited Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832804A (en) * 1958-04-29 Production of i-aminoindan derivatives
US2712031A (en) * 1953-10-27 1955-06-28 Lasdon Foundation Inc Monosubstituted salicylaldehyde alkoximes
US3060177A (en) * 1957-11-11 1962-10-23 Ciba Geigy Corp O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes
US3951983A (en) * 1970-11-10 1976-04-20 Pfizer Inc. Phenoxypropanolpiperazines
SE371193B (OSRAM) * 1972-03-24 1974-11-11 Kabi Ab
US3954763A (en) * 1972-04-10 1976-05-04 Synthelabo N-Metatrifluoromethylthiophenyl-piperazine
GB1415505A (en) * 1972-06-01 1975-11-26 Ici Ltd Alkanolamine derivatives
CA1012540A (en) * 1972-06-17 1977-06-21 Sumitomo Chemical Company 2-propanol derivatives and preparation thereof
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
US3953449A (en) * 1973-05-09 1976-04-27 Synthelabo 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US3960956A (en) * 1974-11-21 1976-06-01 E. I. Du Pont De Nemours & Company Antidepressant 1,1a,6,10b-tetrahydrodibenzo(a,e)-cyclo-propa(c) cyclohepten-6-substituted oximes
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
DK149043C (da) * 1976-01-27 1986-05-26 Egyt Gyogyszervegyeszeti Gyar Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
HU177453B (en) 1981-10-28
AU3181177A (en) 1979-06-28
SE7714685L (sv) 1978-06-25
IL53674A0 (en) 1978-03-10
GB1543517A (en) 1979-04-04
US4328227A (en) 1982-05-04
ES465204A1 (es) 1978-09-16
DE2658938A1 (de) 1978-07-06
JPS54141784A (en) 1979-11-05
DK575277A (da) 1978-06-25
JPS5379875A (en) 1978-07-14
IL53674A (en) 1981-10-30
ES469456A1 (es) 1979-04-01
CA1105933A (en) 1981-07-28
IE46226B1 (en) 1983-04-06
AU512353B2 (en) 1980-10-09
PT67444B (en) 1979-09-20
AT360544B (de) 1981-01-12
GR70042B (OSRAM) 1982-07-26
JPS5677275A (en) 1981-06-25
ATA924777A (de) 1980-06-15
FR2375225A1 (fr) 1978-07-21
PL112153B1 (en) 1980-09-30
PT67444A (en) 1978-01-01
PL111792B1 (en) 1980-09-30
BE862303A (fr) 1978-06-23
LU78770A1 (OSRAM) 1978-07-11
FR2375225B1 (OSRAM) 1980-06-20
NO774456L (no) 1978-06-27
ES469455A1 (es) 1978-12-01
IE46226L (en) 1978-06-24
ZA777586B (en) 1978-11-29
PL110753B1 (en) 1980-07-31
FI773903A7 (fi) 1978-06-25
JPS5695166A (en) 1981-08-01
IT1089233B (it) 1985-06-18
PL203359A1 (pl) 1978-10-23

Similar Documents

Publication Publication Date Title
NL167688C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met bloeddrukverlagende werking en werkwijze voor het bereiden van een verbinding geschikt voor toepassing bij voornoemde werkwijze.
NL7701584A (nl) Werkwijze voor het bereiden van geneesmiddelen met antihypertensieve werking.
NL190049C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met anti-inflammatoire werking.
NL185563C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat en werkwijze voor het bereiden van daarbij toepasbare gesubstitueerde 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepines.
NL7701679A (nl) Werkwijze voor het bereiden van een voedsel- preparaat.
NL172917C (nl) Werkwijze voor het bereiden van een geneesmiddel tegen kanker.
NL930086I2 (nl) Werkwijze voor het bereiden van 2-cyclopropylamino-4,6-diamino-s-triazinen, werkwijze voor het bereiden van een preparaat voor het bestrijden van insekten.
NL7701107A (nl) Werkwijze voor het bereiden van preparaten met een therapeutische werking, de al- dus verkregen gevormde preparaten, werkwijze voor het bereiden van 1,2-dithioolverbindingen alsmede de aldus bereide 1,2-dithioolverbindingen.
NL7702537A (nl) Oxadiazool-derivaten, werkwijze voor het bereiden daarvan alsmede werkwijze voor het bereiden van een op deze verbindingen gebaseerd geneesmiddel met anti-diarrheale werking.
NL7713005A (nl) Werkwijze voor het bereiden van een alkydhars- materiaal en voorwerpen, vervaardigd onder toe- passing van het aldus bereide alkydharsmateriaal.
NL7601085A (nl) Werkwijze voor het bereiden van oxadiazolinon- -verbindingen, werkwijze voor het bereiden van preparaten met een insekticide, acaricide en nematocide werking, alsmede de gevormde prepa- raten.
NL7707618A (nl) Werkwijze voor de bereiding van een kristallijn polypropeenmateriaal en voorwerpen, vervaardigd onder toepassing van het aldus bereide materi- aal.
NL7707555A (nl) Ceriumsulfadiazinen en werkwijze voor de be- reiding daarvan, werkwijze voor de bereiding van preparaten en preparaten gevormd met de werkwijze.
NL7707785A (nl) Werkwijze voor de bereiding van n-gesubstitu- eerde chinazolinen met antihypertensieve wer- king, werkwijze voor de bereiding van een ge- neesmiddel met een dergelijke werking en ge- vormd geneesmiddel.
NL7703001A (nl) Voor hemodialyse geschikte membranen, alsmede werkwijze voor het bereiden daarvan.
NL7704760A (nl) Werkwijze voor de bereiding van 4-aminopiperi- dinen, werkwijze voor de bereiding van een ge- neesmiddel met antihypertensieve werking en een dergelijk geneesmiddel.
NL7702369A (nl) 4-androsteen-3-onen en werkwijze voor het be- reiden daarvan, alsmede werkwijze voor het be- reiden van een geneesmiddel met diuretische werking.
NL7709488A (nl) Werkwijze voor het bereiden van een preparaat met insecticide en acaricide werking.
NL7908304A (nl) Cefem-verbindingen, werkwijze voor het bereiden daarvan, alsmede werkwijze voor het bereiden van een geneesmiddel op basis van deze verbindingen.
NL7704218A (nl) Corticoiden, werkwijze voor het bereiden daar- van, alsmede werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking.
NL7705839A (nl) Werkwijze ter bereiding van een geneesmiddel te- gen oogziekten en het aldus gevormde geneesmid- del.
NL7703239A (nl) Werkwijze voor de bereiding van een geneesmiddel met anti-ulcus en diuretische werking, een der- gelijk geneesmiddel en werkwijze voor de berei- ding van de werkzame verbindingen.
NL7710525A (nl) Werkwijze voor de bereiding van een polyure- thaanschuim en voorwerpen, vervaardigd onder toepassing van het aldus bereide schuim.
NL7713595A (nl) Corticoiden, werkwijze voor het bereiden daar- van alsmede werkwijze voor het bereiden van een geneesmiddel met anti-flogistische werking.
NL163781C (nl) Werkwijze voor de bereiding van acryloxyalkyl- piperdinederivaten, werkwijze voor de bereiding van een preparaat met bloeddrukverlagende werking en gevormd preparaat.

Legal Events

Date Code Title Description
BV The patent application has lapsed